CN104095883A - 珊瑚萃取物及其萃取方法以及其用途、珊瑚萃取物保养品 - Google Patents
珊瑚萃取物及其萃取方法以及其用途、珊瑚萃取物保养品 Download PDFInfo
- Publication number
- CN104095883A CN104095883A CN201410066589.5A CN201410066589A CN104095883A CN 104095883 A CN104095883 A CN 104095883A CN 201410066589 A CN201410066589 A CN 201410066589A CN 104095883 A CN104095883 A CN 104095883A
- Authority
- CN
- China
- Prior art keywords
- extract
- corallium japonicum
- japonicum kishinouye
- thing
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 120
- 238000000605 extraction Methods 0.000 title claims abstract description 32
- 235000014653 Carica parviflora Nutrition 0.000 title abstract 5
- 241000243321 Cnidaria Species 0.000 title abstract 4
- 230000036541 health Effects 0.000 title description 3
- 244000132059 Carica parviflora Species 0.000 title 1
- 241001450685 Corallium japonicum Species 0.000 claims abstract description 93
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 87
- 230000029663 wound healing Effects 0.000 claims abstract description 22
- 241000127209 Briareum excavatum Species 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- 239000012046 mixed solvent Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 11
- -1 chloride alkanes Chemical class 0.000 claims description 11
- 239000012044 organic layer Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 238000004080 punching Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 8
- 150000001298 alcohols Chemical class 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 230000037394 skin elasticity Effects 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 238000004440 column chromatography Methods 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 36
- 238000012360 testing method Methods 0.000 description 28
- 230000000694 effects Effects 0.000 description 27
- 102000003425 Tyrosinase Human genes 0.000 description 21
- 108060008724 Tyrosinase Proteins 0.000 description 21
- 206010053615 Thermal burn Diseases 0.000 description 20
- 206010052428 Wound Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 20
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 238000000338 in vitro Methods 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 15
- 241000700159 Rattus Species 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 241000251468 Actinopterygii Species 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 230000031700 light absorption Effects 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000012930 cell culture fluid Substances 0.000 description 7
- 241000124001 Alcyonacea Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 210000004969 inflammatory cell Anatomy 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 230000036564 melanin content Effects 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 241000252212 Danio rerio Species 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 210000003606 umbilical vein Anatomy 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 210000005081 epithelial layer Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000013401 experimental design Methods 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 240000000254 Agrostemma githago Species 0.000 description 1
- 235000009899 Agrostemma githago Nutrition 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 241000006776 Briareum Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000700108 Ctenophora <comb jellyfish phylum> Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical class [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000003661 hair follicle regeneration Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000010023 transfer printing Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 229940072040 tricaine Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/614—Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102111780 | 2013-04-01 | ||
TW102111780A TWI487539B (zh) | 2013-04-01 | 2013-04-01 | 用於皮膚美白、保濕、改善彈性以及傷口癒合之珊瑚萃取物及其用途、保養品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104095883A true CN104095883A (zh) | 2014-10-15 |
Family
ID=51621063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410066589.5A Pending CN104095883A (zh) | 2013-04-01 | 2014-02-26 | 珊瑚萃取物及其萃取方法以及其用途、珊瑚萃取物保养品 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20140294745A1 (zh) |
CN (1) | CN104095883A (zh) |
TW (1) | TWI487539B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101688453B1 (ko) * | 2016-06-20 | 2016-12-22 | 박지영 | 피부 미백, 모공축소, 및 피지분비 억제용 화장료 조성물 |
CN109010225A (zh) * | 2018-08-22 | 2018-12-18 | 海南热带海洋学院 | 一种珊瑚礁剥离型面膜及其制备方法 |
CN111317748A (zh) * | 2018-12-14 | 2020-06-23 | 中山大学 | 珊瑚复合萃取物、含此的组成物及其制造方法 |
CN115671148A (zh) * | 2021-07-28 | 2023-02-03 | 台湾中山大学 | 一种海木耳萃取物及其用途 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3112283A1 (fr) * | 2020-07-07 | 2022-01-14 | L'oreal | Compositions anti-acné |
EP4153127A1 (en) * | 2020-05-19 | 2023-03-29 | L'oreal | Anti-acne compositions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057877A (zh) * | 2006-04-21 | 2007-10-24 | 中国医学科学院药物研究所 | 草珊瑚提取方法、提取物及其药物组合物与用途 |
TW200823220A (en) * | 2006-11-28 | 2008-06-01 | Nat Museum Of Marine Biology & Amp Aquarium | Novel briarane-related diterpenoid compound, its preparing and application method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050244427A1 (en) * | 2004-02-20 | 2005-11-03 | Kerr Russell G | Isolation and production of bioactive marine products |
WO2009118734A2 (en) * | 2008-03-27 | 2009-10-01 | Ramot At Tel Aviv University Ltd. | Coral-derived collagen and methods of farming same |
US20090258091A1 (en) * | 2008-04-09 | 2009-10-15 | Marine Bio Co., Ltd. | Compositions and methods for treating neurodegenerative diseases |
-
2013
- 2013-04-01 TW TW102111780A patent/TWI487539B/zh active
-
2014
- 2014-01-22 US US14/160,727 patent/US20140294745A1/en not_active Abandoned
- 2014-02-26 CN CN201410066589.5A patent/CN104095883A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057877A (zh) * | 2006-04-21 | 2007-10-24 | 中国医学科学院药物研究所 | 草珊瑚提取方法、提取物及其药物组合物与用途 |
TW200823220A (en) * | 2006-11-28 | 2008-06-01 | Nat Museum Of Marine Biology & Amp Aquarium | Novel briarane-related diterpenoid compound, its preparing and application method |
Non-Patent Citations (2)
Title |
---|
New briaranes from the octocorals Briareum excavatum (Briareidae) and Junceella fragilis (Ellisellidae);Ping-Jyun Sung,et al.;《tetrahedron》;20080111;第2602页"3.3.1"项下 * |
中国珊瑚化学成分与生物活性研究新进展;艾小红,等。;《广州大学学报》;20060228;第5卷(第1期);第49-56页。 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101688453B1 (ko) * | 2016-06-20 | 2016-12-22 | 박지영 | 피부 미백, 모공축소, 및 피지분비 억제용 화장료 조성물 |
CN109010225A (zh) * | 2018-08-22 | 2018-12-18 | 海南热带海洋学院 | 一种珊瑚礁剥离型面膜及其制备方法 |
CN111317748A (zh) * | 2018-12-14 | 2020-06-23 | 中山大学 | 珊瑚复合萃取物、含此的组成物及其制造方法 |
US11628191B2 (en) | 2018-12-14 | 2023-04-18 | National Sun Yat-Sen University | Coral composite extract, composition including the same and method of producing the same |
US11738055B2 (en) | 2018-12-14 | 2023-08-29 | National Sun Yat-Sen University | Coral composite extract, composition including the same and method of producing the same |
US11963985B2 (en) | 2018-12-14 | 2024-04-23 | National Sun Yat-Sen University | Coral composite extract, composition including the same and method of producing the same |
CN115671148A (zh) * | 2021-07-28 | 2023-02-03 | 台湾中山大学 | 一种海木耳萃取物及其用途 |
CN115671148B (zh) * | 2021-07-28 | 2023-10-03 | 台湾中山大学 | 一种海木耳萃取物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
TW201438760A (zh) | 2014-10-16 |
TWI487539B (zh) | 2015-06-11 |
US20140294745A1 (en) | 2014-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104095883A (zh) | 珊瑚萃取物及其萃取方法以及其用途、珊瑚萃取物保养品 | |
CN103785064B (zh) | 一种皮肤模型及应用 | |
CN103655257B (zh) | 一种中药育发洗发露及其制备方法 | |
CA2410956C (en) | Three-dimensional skin model | |
US10092495B2 (en) | Use of a composition comprising avocado perseose in the protection of epidermal stem cells | |
CN101969915A (zh) | 皮肤美白方法以及皮肤斑形成抑制和/或除去因子的筛选方法 | |
CN103937740B (zh) | 间充质系干细胞的导引剂和间充质系干细胞的导引方法 | |
CN106265740B (zh) | 脐带间充质干细胞联合黄芪多糖在制备治疗高血糖和糖尿病肾病药物中的应用 | |
CN103983762A (zh) | 含黑色素细胞的皮肤模型、其构建方法及用途 | |
JP5275898B2 (ja) | 皮膚状態の評価方法 | |
CN113876633B (zh) | 一种仿人体皮脂脂质构成的天然植物油脂复合物及其制备方法和用途 | |
CN101491485A (zh) | 含有水飞蓟宾糖苷的皮肤外用组合物 | |
CN101570739B (zh) | 银屑病基础研究模型的建立方法及气液平面跨膜装置 | |
CN103764816B (zh) | 重建头皮模型和筛选活性分子的方法 | |
CN103372046A (zh) | 促进伤口愈合的医药组合物与接骨木属(蒴藋属)植物或菘蓝属植物用于制备促进伤口愈合之药物的用途 | |
RU2801049C1 (ru) | Способ установления возрастной принадлежности неизвестного человека при проведении судебно-медицинской экспертизы | |
CN105998118B (zh) | 竹节参总皂苷在制备预防及治疗肝脏衰老的药物上的应用 | |
Maulidi et al. | Effectiveness Of Ethanol Extract Of Turmeric (Curcuma Domestic Valet) Gel Against Grade Iia Burn In White Rats (Rattus Norvegicus) | |
Coelho et al. | FT-Raman spectroscopic study of skin wound healing in diabetic rats treated with Cenostigma macrophyllum Tul | |
CN109602631A (zh) | 秦皮甲素在制备抗皮肤光老化护肤品中的应用 | |
JP6113981B2 (ja) | スクリ−ニング方法 | |
Asgari et al. | Hair transplantation in mice: challenges and solutions | |
CN115058459B (zh) | 草本与珍珠粉结合的抗炎美白亮肤祛斑组合制备方法及其应用 | |
Holmes | Living tissues: an introduction to functional histology | |
CN107258691A (zh) | 一种提升罗仙子油脂药用价值的饲养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NATIONAL MUSEUM OF MARING BIOLOGY + AQUARIUM GUOLI Effective date: 20150601 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150601 Address after: Taiwan, Tainan, China Industrial Zone, No. two, No. 31 Applicant after: Uni-President Biotech Co.,Ltd. Applicant after: National Museum of Marine Biology and Aquarium Applicant after: Univ Nat Sun Yat Sen Address before: Taiwan, Tainan, China 70955 Annan District Industrial two road, No. 31 Applicant before: Uni-President Biotech Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141015 |
|
WD01 | Invention patent application deemed withdrawn after publication |